Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Human IL-36 gamma/IL-1F9 Antibody, R&D Systems™

Goat Polyclonal Antibody has been used in 3 publications
Supplier: R&D Systems AF2320SP
This item is not returnable.
View return policy
Description
IL-36 gamma/IL-1F9 Polyclonal specifically detects IL-36 gamma/IL-1F9 in Human samples. It is validated for Western Blot, Blockade of Receptor-ligand Interaction.Specifications
IL-36 gamma/IL-1F9 | |
Polyclonal | |
Unconjugated | |
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative | |
IL-1 epsilon, IL-1 H1, IL-1 Related Protein 2, IL-1(EPSILON), IL1E, IL-1-epsilon, IL1F9, IL-1F9, IL1H1, IL-1H1, IL-1-Related Protein 2, IL1RP2, IL-1RP2, IL36 gamma, IL36G, interleukin 1 family, member 9, interleukin 1-related protein 2, Interleukin 36, Gamma, Interleukin-1 epsilon, interleukin-1 family member 9, Interleukin-1 homolog 1, Interleukin-36 Gamma | |
Goat | |
Affinity Purified | |
RUO | |
56300 | |
Reconstitute at 0.2 mg/mL in sterile PBS. | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. |
Western Blot, Blockade of Receptor-ligand Interaction | |
LYOPH | |
Western Blot 0.5 ug/mL, Blockade of Receptor-ligand Interaction 10 ug/mL | |
Q9NZH8 | |
IL36G | |
E. coli-derived recombinant human IL-36 gamma/IL-1F9 (R&D Systems, Catalog # 2320-IL) Met1-Asp169 Accession # Q9NZH8 | |
25 μg | |
Primary | |
Detects human IL-36 gamma/IL-1F9 in direct ELISAs and Western blots. In direct ELISAs, approximately 15% cross-reactivity with recombinant human (rh) IL-36 alpha is observed, approximately 5% cross-reactivity with rhIL-37 is observed, and less than 1% cross-reactivity with rhIL-1 alpha , rhIL-1 beta , rhIL-36Ra, and rhIL-36 beta is observed. | |
Human | |
IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction